Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis
Duke Chen,1,* Yu-Shen Wu,2,* Huapeng Lin,3,* Yihan Wang,1 Longhao Li,1 Tao Zhang1 1Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 2Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affili...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-08-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-and-safety-of-tas-102-in-refractory-metastatic-colorectal-can-peer-reviewed-article-CMAR |